Fasting Plus Prandial Insulin Supplements Improve Insulin Secretory Ability in NIDDM Subjects
Authors:
- 1 November 1989
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 12 (10) , 680-685
Abstract
To examine how insulin secretory ability is modified by strict glycemic control in non-insulin-dependent diabetes mellitus (NIDDM) subjects, basal and/or prandial insulin was supplemented for 4 wk in 24 diabetic subjects who were secondary failures to sulfonylurea treatment. One intermediate-acting insulin injection a day (n = 7) failed to suppress the rise in plasma C-peptide after meals and did not improve plasma C-peptide responses during a posttreatment oral glucose challenge. Continuous subcutaneous insulin infusion with a premeal bolus (n = 8) suppressed both fasting and meal-related rises in C-peptide and improved C-peptide response during the posttreatment oral glucose challenge. Daily insulin requirements during the 4 wk of treatment were reduced significantly by 52%. A short-acting insulin injection before each meal (n = 9) without basal supplementation suppressed the prandial rise in C-peptide and was associated with a significant reduction in daily insulin requirements during 4 wk of treatment by 28%. Diabetic subjects whose fasting and prandial hyperglycemia were <140 and <200 mg/dl, respectively, showed a significantly higher C-peptide response during oral glucose challenge after treatment than those whose insulin treatment only normalized (140 mg/dl). These results suggest that a short-term period of meal-related insulin treatment (which normalized prandial glycemia) increases residual β-cell function in NIDDM subjects who failed long-term sulfonylurea administration. A basal insulin supplement alone was not effective. The effectiveness of a prandial insulin supplement may have been further improved by a combined basal and meal-related treatment programKeywords
This publication has 9 references indexed in Scilit:
- Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetesEuropean Journal of Endocrinology, 1988
- Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.Journal of Clinical Investigation, 1983
- Improvement of Insulin Secretion but Not Insulin Resistance after Short Term Control of Plasma Glucose in Obese Type II Diabetics*The Journal of Clinical Endocrinology & Metabolism, 1982
- The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemiaMetabolism, 1982
- TREATMENT OF A TYPE II DIABETIC BY A TOTALLY IMPLANTABLE INSULIN INFUSION DEVICEThe Lancet, 1981
- Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patientsMetabolism, 1980
- Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*The Journal of Clinical Endocrinology & Metabolism, 1979
- Effects of Hyper- and Hypoglycemia on Beta Cell Degranulation and Glycogen Infiltration in Normal, Subdiabetic and Diabetic RatsDiabetes, 1967
- Immunoassay of insulin with insulin-antibody precipitateBiochemical Journal, 1963